Viehbacher, “Biogen”) announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of “LEQEMBI ® ” (brand name in China: “??? ® ”, ...

Mahatma Gandhi University has released the TS ICET 2026 notification for MBA and MCA aspirants, with registrations starting ...

Mahatma Gandhi University has released the TS ICET 2026 notification for MBA and MCA admissions. Registration starts on 12 ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...

The TS ICET 2026 registration process will begin on February 12, 2026, has released the official notification for the Telangana Integrated Common Entrance Test (TS ICET) 2026.

Shilpa Medicare Limited has informed stock exchanges that it has filed an Abbreviated New Drug Application (ANDA) with the ...

Stockholm, Sweden Tuesday, February 10, 2026, 14:00 Hrs [IST] ...

Hyderabad: Gland Pharma Limited, a generic injectable and ophthalmic-focused pharmaceutical company, has received approval ...

Leqembi is the result of a strategic research alliance between BioArctic and Eisai. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril ...

For patients with noncardioembolic ischemic stroke or high-risk transient ischemic attack, asundexian, a factor XIa inhibitor ...

Veradermics, Incorporated , a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological conditions, ...